Histiocytosis development and clinical variation through the lens of genomics
The Journal of Pathology · 2026-09 · 270 (1) · 23-39
DOI: 10.1002/path.70081 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Pathology, online erschienen am 27.05.2026. Verfasst von Paul G Kemps und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Genomics, Histiocytosis. Die Arbeit nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leiden University Medical Center, Histiocytosis Association, Histiocytosis UK.
Abstract (Originalsprache)
Histiocytic neoplasms are rare haematologic diseases characterised by clonal expansions of cells with a monocyte, macrophage or dendritic cell phenotype. Their clinical manifestations are diverse, ranging from indolent lesions to aggressive systemic disease. Over recent decades, advances in genomic profiling have transformed the biological understanding of these conditions. The discovery of recurrent oncogenic mutations has reframed histiocytoses from primary inflammatory disorders to myeloid neoplasms, with a notable dependence on aberrant mitogen‐activated protein kinase (MAPK) signalling. Novel genetic drivers continue to be uncovered, with many alterations correlating with distinct clinical and pathological phenotypes. Parallel studies have refined the understanding of disease ontogeny, demonstrating that diverse histiocytoses originate from haematopoietic stem/progenitor cells. In Langerhans cell histiocytosis, the differentiation stage of the mutated precursor cell is considered an important — but not the sole — determinant of disease extent and severity. Additional evidence suggests that specific clinical manifestations, such as neurodegenerative disease, may result from somatic mosaicism affecting tissue‐resident macrophages derived from yolk sac progenitors. Collectively, these findings refine histiocytosis diagnosis, risk stratification, disease monitoring and treatment, with robust activity of kinase inhibitors in patients with severe or refractory disease. In this review, we synthesise recent genomic insights into histiocytosis development and variation, while addressing remaining questions and future directions. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
- Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Internal Medicine, Section Allergology & Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Pathology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium.
ORCID-Profile: Paul G Kemps, Astrid Gs van Halteren, Tom van Wezel, Pancras Cw Hogendoorn
Förderung
- Leiden University Medical Center
- Histiocytosis Association
- Histiocytosis UK
- Stichting Histiocytose Nederland
- Stichting 1000 Kaarsjes voor Juultje
- Stichting Kiwanis Run-for-LCH
- Stichting de Merel
- Leids Universitair Medisch Centrum
Zitieren
APA
Kemps, P. G., van Halteren, A. G., van Wezel, T., & Hogendoorn, P. C. (2026). Histiocytosis development and clinical variation through the lens of genomics. The Journal of Pathology, 270(1), 23-39. https://doi.org/10.1002/path.70081
Vancouver
Kemps PG, van Halteren AG, van Wezel T, Hogendoorn PC. Histiocytosis development and clinical variation through the lens of genomics. The Journal of Pathology. 2026;270(1):23-39. doi:10.1002/path.70081
BibTeX
@article{Kemps2026,
author = {Kemps, Paul G and van Halteren, Astrid Gs and van Wezel, Tom and Hogendoorn, Pancras Cw},
title = {Histiocytosis development and clinical variation through the lens of genomics},
journal = {The Journal of Pathology},
year = {2026},
volume = {270},
number = {1},
pages = {23--39},
doi = {10.1002/path.70081}
}
EUVIMED